| Literature DB >> 30226161 |
Aubree Gordon, Tim K Tsang, Benjamin J Cowling, Guillermina Kuan, Sergio Ojeda, Nery Sanchez, Lionel Gresh, Roger Lopez, Angel Balmaseda, Eva Harris.
Abstract
During August 2012-November 2014, we conducted a case ascertainment study to investigate household transmission of influenza virus in Managua, Nicaragua. We collected up to 5 respiratory swab samples from each of 536 household contacts of 133 influenza virus-infected persons and assessed for evidence of influenza virus transmission. The overall risk for influenza virus infection of household contacts was 15.7% (95% CI 12.7%-19.0%). Oseltamivir treatment of index patients did not appear to reduce household transmission. The mean serial interval for within-household transmission was 3.1 (95% CI 1.6-8.4) days. We found the transmissibility of influenza B virus to be higher than that of influenza A virus among children. Compared with households with <4 household contacts, those with >4 household contacts appeared to have a reduced risk for infection. Further research is needed to model household influenza virus transmission and design interventions for these settings.Entities:
Keywords: H1N1; H3N2; Managua; Nicaragua; age; household; household contacts; household transmission; influenza; influenza A; influenza B; oseltamivir; respiratory infections; risk for infection; serial interval; transmission; vaccination; viruses
Mesh:
Year: 2018 PMID: 30226161 PMCID: PMC6154158 DOI: 10.3201/eid2410.161258
Source DB: PubMed Journal: Emerg Infect Dis ISSN: 1080-6040 Impact factor: 6.883
Figure 1Timeline of enrollment of index cases of PCR-confirmed monoinfections of seasonal influenza A(H1N1) virus, influenza A(H3N2) virus, or influenza B virus, Managua, Nicaragua, August 2012–November 2014. Only the index cases included in the final analysis are shown.
Characteristics of influenza virus–infected index cases-patients and household contacts, Managua, Nicaragua, August 2012–November 2014*
| Characteristic | Influenza type, no./total (%) | Total, no. (%) | ||
|---|---|---|---|---|
| A(H1N1) | A(H3N2) | B | ||
| Index patients | 16 | 80 | 37 | 133 |
| Age, y | ||||
|
| 10 (63) | 52 (65) | 15 (41) | 77 (58) |
| 6−18 | 5 (31) | 23 (29) | 21 (57) | 49 (37) |
| >18 | 1 (6) | 5 (6) | 1 (3) | 7 (5) |
| Sex | ||||
| F | 6 (38) | 36 (45) | 17 (46) | 59 (44) |
| M | 10 (63) | 44 (55) | 20 (54) | 74 (56) |
| Prior vaccination | ||||
| Yes | 1 (6) | 2 (3) | 3 (8) | 6 (5) |
| No | 15 (94) | 78 (98) | 34 (92) | 127 (95) |
| Oseltamivir treatment | ||||
| Yes | 16 (100) | 53 (66) | 32 (86) | 101 (76) |
| No | 0 | 27 (34) | 5 (14) | 32 (24) |
| No. household contacts | ||||
| 1–3 | 6 (38) | 44 (55) | 23 (62) | 73 (55) |
| 4–5 | 5 (31) | 19 (24) | 6 (16) | 30 (23) |
| >5 | 5 (31) | 17 (21) | 8 (22) | 30 (23) |
| No. secondary cases in household | ||||
| 0 | 10 (63) | 54 (68) | 17 (46) | 81 (61) |
| 1 | 4 (25) | 16 (20) | 14 (38) | 34 (26) |
| 2 | 1 (6) | 4 (5) | 5 (14) | 10 (8) |
| >2 | 1 (6) | 6 (8) | 1 (3) | 8 (6) |
| Household contacts | 67 | 322 | 147 | 536 |
| Age, y | ||||
|
| 30 (45) | 147 (46) | 64 (44) | 241 (45) |
| >18 | 37 (55) | 175 (54) | 83 (56) | 295 (55) |
| Sex | ||||
| F | 46 (69) | 202 (63) | 94 (64) | 342 (64) |
| M | 21 (31) | 120 (37) | 53 (36) | 194 (36) |
| Prior vaccination | ||||
| Yes | 3 (4) | 9 (3) | 20 (14) | 32 (6) |
| No | 64 (96) | 313 (97) | 127 (86) | 504 (94) |
| With confirmed infection | ||||
| Overall | 9/67 (13) | 46/322 (14) | 29/147 (20) | 84/536 (16) |
|
| 3/30 (10) | 33/147 (22) | 21/64 (33) | 57/241 (24) |
| >18 y† | 6/37 (16) | 13/175 (7) | 8/83 (10) | 27/295 (9) |
| No. confirmed infections without reported symptoms | ||||
| Overall | 2/9 (22) | 15/46 (33) | 4/29 (14) | 21/84 (25) |
|
| 2/3 (67) | 11/33 (33) | 3/21 (14) | 16/57 (28) |
| >18 y† | 0/6 | 4/13 (31) | 1/8 (13) | 5/27 (19) |
*Not all percentages add up to 100% because of rounding. †The denominator is the number of infected household contacts in the corresponding age group.
Factors affecting influenza transmission in urban households, Managua, Nicaragua, August 2012–November 2014
| Characteristics | Risk ratio (95% CI) |
|---|---|
| Influenza type | |
| A(H3N2) | Referent |
| A(H1N1) | 1.18 (0.5–2.42) |
| B | 0.96 (0.4–2.15) |
| Age of household contact, y | |
| >18 | Referent |
|
| 2.26 (1.38–3.88) |
|
| 4.47 (2.05–11.02) |
| Prior vaccination of household contact | |
| No | Referent |
| Yes | 0.46 (0.11–1.32) |
| Age of index patient, y | |
|
| Referent |
| >5 | 1.55 (0.98–2.45) |
| Oseltamivir treatment of index case | |
| No | Referent |
| Yes | 0.69 (0.42–1.12) |
| No. household contacts | |
| 1–3 | Referent |
| 4–5 | 0.60 (0.30–1.10) |
| >5 | 0.69 (0.37–1.18) |
Figure 2Observed and estimated risks for influenza virus infection of household contacts of index patients with reverse transcription PCR–confirmed influenza virus infections, by characteristic, Managua, Nicaragua, August 2012–November 2014. We estimated risk for infection by performing simulations using a multivariate model fitted to the collected data. Estimates represent 10,000 simulated epidemics in households with a structure that matched exactly that of the observed household. Points indicate medians, and bars represent the 2.5%–97.5% ranges of those 10,000 simulations. Risks for infection are shown for A) child and adult household contacts with influenza A virus infection or influenza B virus infection; B) virus type and subtype; C) vaccinated and nonvaccinated household contacts; D) household contact number; E) age group; and F) household contacts of index patients who were and were not treated with oseltamivir.